Search results: Sage Journals

Restricted accessResearch articleFirst published September, 2019

Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors

Roland Coppens, Johanna Yang, Sunita Ghosh [...]

Journal of Oncology Pharmacy Practice

Restricted accessReview articleFirst published December, 2015

Discontinuing Pneumocystis jirovecii Pneumonia Prophylaxis in HIV-Infected Patients With a CD4 Cell Count <200 cells/mm 3

Vaninder K. Sidhu, Michelle M. Foisy, Christine A. Hughes

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published December, 2021

Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for Pneumocystis jirovecii pneumonia in pediatric oncology patients

Monica Awad, Caroline M Sierra, Elhaam Mesghali [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published August, 2016

Pneumocystis jirovecii Pneumonia in the Non–HIV-Infected Population

Laura J. Avino, Shane M. Naylor, Andrew M. Roecker

Annals of Pharmacotherapy

Restricted accessReview articleFirst published November, 2009

Fact or Fiction: Does the Non-HIV/AIDS: Immunosuppressed Patient Need Pneumocystis Jiroveci Pneumonia Prophylaxis? An Updated Literature Review

Parbeer Grewal, Alain Brassard

Journal of Cutaneous Medicine and Surgery

Open accessResearch articleFirst published 2018

The Impact of Absolute CD4 Count and Percentage Discordance on Pneumocystis Jirovecii Pneumonia Prophylaxis in HIV-Infected Patients

Henry Anyimadu, Chandra Pingili, Vel Sivapalan [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Open accessReview articleFirst published 2015

Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak

Norihiko Goto, Kenta Futamura, Manabu Okada [...]

Therapeutic Advances in Pulmonary and Critical Care Medicine

Restricted accessResearch articleFirst published 2026

Pneumocystis jirovecii Pneumonia in Non-HIV,Non-HCT Adults: Real-World Patterns of Overlapping Immunosuppression and PJP-Active Therapy

Daniel B. Chastain, Dustin M. Solorzano-Salazar, Aditya Mantha [...]

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published July, 2025

Evaluation of the Incidence of Nocardia Infection in Solid Organ Transplant Recipients on Trimethoprim-Sulfamethoxazole for Opportunistic Infection Prophylaxis

Regina Jung, Jenny Au, Jacqueline Burnell [...]

Annals of Pharmacotherapy

Restricted accessCase reportFirst published September, 2023

Hidden consequences: Uncovering belimumab’s role in the development of Pneumocystis jirovecii pneumonia in a lupus patient

Maria Ng, Meggan Mackay, Pranisha Gautam-Goyal [...]

Lupus

Restricted accessResearch articleFirst published September, 2019

Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors

Roland Coppens, Johanna Yang, Sunita Ghosh [...]

Journal of Oncology Pharmacy Practice

Restricted accessReview articleFirst published December, 2015

Discontinuing Pneumocystis jirovecii Pneumonia Prophylaxis in HIV-Infected Patients With a CD4 Cell Count <200 cells/mm 3

Vaninder K. Sidhu, Michelle M. Foisy, Christine A. Hughes

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published December, 2021

Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for Pneumocystis jirovecii pneumonia in pediatric oncology patients

Monica Awad, Caroline M Sierra, Elhaam Mesghali [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published August, 2016

Pneumocystis jirovecii Pneumonia in the Non–HIV-Infected Population

Laura J. Avino, Shane M. Naylor, Andrew M. Roecker

Annals of Pharmacotherapy

Restricted accessReview articleFirst published November, 2009

Fact or Fiction: Does the Non-HIV/AIDS: Immunosuppressed Patient Need Pneumocystis Jiroveci Pneumonia Prophylaxis? An Updated Literature Review

Parbeer Grewal, Alain Brassard

Journal of Cutaneous Medicine and Surgery

Open accessResearch articleFirst published 2018

The Impact of Absolute CD4 Count and Percentage Discordance on Pneumocystis Jirovecii Pneumonia Prophylaxis in HIV-Infected Patients

Henry Anyimadu, Chandra Pingili, Vel Sivapalan [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Open accessReview articleFirst published 2015

Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak

Norihiko Goto, Kenta Futamura, Manabu Okada [...]

Therapeutic Advances in Pulmonary and Critical Care Medicine

Restricted accessResearch articleFirst published 2026

Pneumocystis jirovecii Pneumonia in Non-HIV,Non-HCT Adults: Real-World Patterns of Overlapping Immunosuppression and PJP-Active Therapy

Daniel B. Chastain, Dustin M. Solorzano-Salazar, Aditya Mantha [...]

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published July, 2025

Evaluation of the Incidence of Nocardia Infection in Solid Organ Transplant Recipients on Trimethoprim-Sulfamethoxazole for Opportunistic Infection Prophylaxis

Regina Jung, Jenny Au, Jacqueline Burnell [...]

Annals of Pharmacotherapy

Restricted accessCase reportFirst published September, 2023

Hidden consequences: Uncovering belimumab’s role in the development of Pneumocystis jirovecii pneumonia in a lupus patient

Maria Ng, Meggan Mackay, Pranisha Gautam-Goyal [...]

Lupus